MedTech Terms
    The authoritative reference
    All terms
    Investment & FinanceStartup LifecycleIPO

    Initial Public Offering

    First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

    Definition

    An Initial Public Offering (IPO) is the first sale of a company's equity to public investors through a registered offering filed with the SEC under the Securities Act of 1933 (Form S-1). The process includes pre-filing organizational meetings, drafting the S-1 prospectus, SEC review, the road show, pricing, and listing on a national exchange (NYSE, Nasdaq). MedTech IPO windows are highly cyclical and typically require either commercial-stage revenue or late-stage clinical data with a near-term FDA decision.

    What this means in practice

    For MedTech, the IPO is one of two primary liquidity paths (the other is M&A). Public-company readiness imposes ongoing 10-K, 10-Q, 8-K, SOX 404, and Reg FD obligations that materially change operating cost.
    Common pitfalls
    • •Going public too early — public markets punish missed clinical or commercial milestones harshly.
    • •Underestimating SOX 404(b) internal-control audit costs in the first post-IPO year.

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-05-09
    SEC·2SVB·1
    1. 1
      SEC — Form S-1
      Verified
      SECsec.gov
    2. 2
      SEC — Going Public
      Verified
      SECsec.gov
    3. 3
      Silicon Valley Bank - Healthcare Reports
      Verified
      SVBsvb.com

    Inline markers like [1] jump to the matching reference above.